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ABSTRACT
Background: Safe systemic protection from the health hazards of
ultraviolet radiation (UVR) in sunlight is desirable. Green tea is
consumed globally and is reported to have anti-inflammatory prop-
erties, which may be mediated through the impact on cyclooxygen-
ase and lipoxygenase pathways. Recent data suggest that green tea
catechins (GTCs) reduce acute UVR effects, but human trials ex-
amining their photoprotective potential are scarce.
Objective: We performed a double-blind, randomized, placebo-
controlled trial to examine whether GTCs protect against clinical,
histologic, and biochemical indicators of UVR-induced inflammation.
Design: Healthy adults (aged 18–65 y, phototypes I–II) were ran-
domly allocated to 1350 mg encapsulated green tea extract (540 mg
GTC) with 50 mg vitamin C or placebo twice daily for 3 mo. Impact
on skin erythema, dermal leukocytic infiltration, and concentrations
of proinflammatory eicosanoids was assessed after solar-simulated
UVR challenge, and subject compliance was determined through
assay of urinary GTC metabolite epigallocatechin glucuronide.
Results: Volunteers were assigned to the active (n = 25) or the
placebo (n = 25) group. After supplementation, median (IQR)
sunburn threshold (minimal erythema dose) was 28 (20–28) and
20 (20–28) mJ/cm2 in the active and placebo groups, respectively
(nonsignificant), with no difference in AUC analysis for measured
erythema index after a geometric series of 10 UVR doses. Skin
immunohistochemistry showed increased neutrophil and CD3+
T-lymphocyte numbers post-UVR in both groups (P , 0.01) with no
statistically significant differences between groups after supplementa-
tion. Cyclooxygenase and lipoxygenase metabolites prostaglandin
E2 (vasodilator) and 12-hydroxyeicosatetraenoicacid (chemoattrac-
tant), respectively, increased after UVR (P , 0.05), with no differ-
ences between supplementation groups.
Conclusion: Oral GTC (1080 mg/d) with vitamin C over 3 mo did
not significantly reduce skin erythema, leukocyte infiltration, or
eicosanoid response to UVR inflammatory challenge. This trial
was registered at clinicaltrials.gov as NCT01032031. Am J
Clin Nutr 2015;102:608–15.
Keywords: green tea catechins, human skin, inflammation, photo-
protection, ultraviolet radiation
INTRODUCTION
The skin has important roles in the body’s defense against
harmful stimuli. Ultraviolet radiation (UVR)7 in sunlight is
a key environmental trigger of acute adverse events, including
dose-related inflammation (sunburn), photosensitivity, immu-
nosuppression, and DNA damage, with repeated exposure
leading to chronic photodamage and photocarcinogenesis.
Topical sunscreens can protect by absorbing and scattering UVR
but have drawbacks, including generally infrequent application
outside of holiday times and inadequate application methods,
with uneven spread and use at surface density considerably
lower than the manufacturers’ sunscreen testing conditions
(1, 2). A dietary approach to photoprotection could provide a con-
tinuous adjunctive measure, with population-level impact (3).
The acute response of the skin to UVR is orchestrated by cells
within the epidermal and dermal layers that release mediators
producing acute inflammation, which presents clinically as er-
ythema and histologically as a dermal leukocytic infiltrate (4, 5).
UVR-induced oxidative stress stimulates expression and activity
of cytosolic phospholipase A2, leading to increased production
of free arachidonic acid, which can be metabolized by cyclo-
oxygenases and lipoxygenases to a wide range of eicosanoids
(6, 7), many of which play roles in inflammation, notably the
cyclooxygenase-2 product prostaglandin (PG) E2, a major mediator
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of UVR-induced erythema (8, 9), and the 12-lipoxygenase–derived
12-hydroxyeicosatetraenoicacid (HETE), a potent leukocyte
chemoattractant (9–11) in the sunburn response.
There is considerable interest in the potential benefits to health
of green tea, which is widely consumed in many parts of the
world. In addition to a broad literature relating to their chemo-
preventive activities (12, 13), green tea catechins (GTCs) have
anti-inflammatory properties (14, 15) and are part of the poly-
phenol group, which can reduce the expression and activity
of cyclooxygenase-2 and several lipoxygenase isoforms (16–
19). The green tea polyphenol (2)-epigallocatechin-3-gallate
(EGCG) has been reported to reduce cyclooxygenase-2 ex-
pression, in addition to UVB-mediated activation of nuclear
transcription factor kB and neutrophil migration in vitro (20–
23), and oral GTCs were protective against UVR-induced skin
inflammation as well as carcinogenesis in hairless mice (24). In
humans, topical application of GTCs before UVR reduced cu-
taneous erythema, leukocyte infiltration, and DNA damage in-
duced by UVR (25), whereas oral consumption was reported to
increase the clinical erythema threshold to UVR (26). In a
before-after pilot study, 12-wk oral GTCs led to incorporation of
GTC metabolites into skin and modest protection against UVR-
induced erythema, alongside reduced 12-HETE production (27).
The above findings indicated the requirement for a double-blind,
randomized controlled trial of adequate sample size to examine in
more depth the photoprotective potential of oral GTCs against
acute UVR insult. We have conducted such a study of 3-mo oral
GTCs with low-dose vitamin C in healthy humans, evaluating its
ability to protect against UVR-induced inflammation by 1) visual
and objective assessment of clinical erythema after a range of
UVR doses, 2) histologic assessment of skin leukocytic infiltrate,
and 3) quantification of the major proinflammatory cyclooxygenase-
and lipoxygenase-derived mediators upregulated in sunburn,
PGE2, and 12-HETE.
METHODS
Study design
Fifty healthy white adults (aged 18–65 y), male and female,
Fitzpatrick sun-reactive skin types I–II, were recruited by open
advertisement. Exclusion criteria were history of skin cancer or
photosensitivity disorder, sunbed use/sunbathing in the 3 mo
before the study, taking photoactive medication or nutritional
supplements, consuming .2 cups of tea/d, or currently pregnant
or breastfeeding. Ethical approval was obtained from the North
Manchester Research Ethics Committee (reference 08/H1006/79).
Written informed consent was obtained from the participants
and the study adhered to Declaration of Helsinki principles. The
study was conducted in the Photobiology Unit, Dermatology
Centre, Salford Royal Hospital, Manchester, United Kingdom,
between November 2010 and August 2011. Subjects were ran-
domly assigned to receive green tea extract plus vitamin C or
placebo maltodextrin (1:1; block randomization with random
block size between 4 and 8; StatsDirect v2.7.8, StatsDirect Ltd.).
Containers containing active and placebo supplement were se-
quentially numbered. Subjects and investigators were blinded to
the intervention, and the randomization code was held securely
until completion of the study.
Green tea supplements were gelatin capsules each containing
450 mg green tea extract (180 mg GTC) (27) and a further set of
capsules each containing 25 mg vitamin C. Actively supple-
mented subjects took 3 green tea and 2 vitamin C capsules twice
daily (with breakfast and evening meal; total daily dose 1080 mg
GTC, 100 mg vitamin C; Table 1) for 12 wk. Low-dose vitamin C
stabilizes the green tea extract in the gut lumen and has been
shown to have no impact itself on UVR erythema (28, 29).
Placebo subjects took supplements comprising maltodextrin in
gelatin capsules of identical appearance to those containing
green tea and vitamin C. The primary outcome was change in
the minimal erythema dose (MED) of UVR at 12 wk. Secondary
outcomes were change in UVR-induced neutrophils and CD3+ T
lymphocytes in skin biopsy sections, as well as PGE2 and
12-HETE in suction blister fluid at 12 wk. All supplements were
provided by Nestec Ltd. and packaged in bottles with identical
appearance by Laboratoire LPH. Compliance was assessed by
counting residual capsules in dispensed containers returned by
volunteers and measurement of the green tea urinary marker
epigallocatechin glucuronide as described below.
UVR exposure and assessment of erythema response
Exposures were performed by using a solar simulator with
emission of UVB and UVA mimicking that of sunlight (emission
290–400 nm; 5% UVB, 95% UVA; Newport Spectra-Physics
Ltd). Irradiance was measured 10 cm from the source before
each irradiation by using a radiometer (model IL 730A; In-
ternational Light) calibrated for use with the light source to
ensure consistency of doses applied.
TheMED of UVR (i.e., the sunburn threshold) for each subject
was assessed at baseline and postsupplementation, after appli-
cation of a geometric series of 10 doses of solar-simulated UVR
(erythemally weighted, 7–80 mJ/cm2) to upper buttock skin
(1-cm-diameter circular sites). Irradiated sites were examined
visually after 24 h, with the MED defined as the lowest dose
producing visually discernible erythema.
Erythema intensity at each of the 10 UVR-exposed sites was
quantified by using a reflectance instrument (Diastron). Readings
were taken in triplicate from each exposed site and from adjacent
unexposed skin and erythema expressed as the difference be-
tween these readings (DE). Dose-response modeling was per-
formed by using a dedicated data analysis package (Regional
Medical Physics Department, Gateshead & Tyneside Health
Authority) to calculate each subject’s D30, the UVR dose pro-
ducing a DE of 30 arbitrary units, which is a threshold value
approximating an individual’s visual MED.
TABLE 1
Total daily amount of green tea extract constituents consumed by active
group subjects
Green tea constituent Amount, mg
Gallic acid 1.8
Catechin 12.6
Epicatechin 75.0
Gallocatechin 74.4
Epigallocatechin 295.8
Catechin gallate 1.8
Epicatechin gallate 156.0
Gallocatechin gallate 28.0
Epigallocatechin gallate 435.6
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Skin biopsy and suction blister fluid sampling
At 24 h before skin tissue and blister fluid sampling, doses of
UVR of 33 the individual’s presupplementation MED were
given to sites on one buttock to provoke an inflammatory re-
sponse sufficient to significantly elevate cutaneous eicosanoid
concentrations (9). UVR-exposed and UVR-protected areas of
upper buttock skin were sampled at baseline and post-
supplementation; UVR exposures were limited to one buttock,
and the other buttock provided the unexposed skin and blister
fluid samples. Skin punch biopsy specimens (5 mm diameter)
were taken after intradermal injection of lignocaine as de-
scribed (9), snap frozen, and stored at 2808C. Suction blisters
were raised by using suctions cups with a central aperture di-
ameter of 1 cm and vacuum of 250 mm Hg as described pre-
viously (9). Skin blister fluid was aspirated with a 23-gauge
needle, snap frozen in liquid nitrogen, and stored at 2808C
until analysis.
Immunohistochemical staining and assessment
Monoclonal anti–neutrophil elastase (clone NP57) and
polyclonal anti-CD3 antibodies were obtained from Dako UK
Ltd. Briefly, frozen biopsy specimens were sectioned (5 mm)
and endogenous peroxidase activity blocked by incubation in
0.6% (vol:vol) hydrogen peroxide in methanol. Sections were
incubated overnight at 48C with primary antibody and then
visualized by using the ImmPRESS system or Vectastain Elite
ABC kit (Vector Laboratories Ltd.) for neutrophil elastase and
CD3, respectively. All sections were blinded and randomized
before assessment. For each biopsy sample, 3 high-power fields
(hpfs) were assessed microscopically from each of 3 biopsy
sections. Cell number per hpf was determined for neutrophils
and CD3+ T lymphocytes.
Analysis of skin blister fluid
Eicosanoids in skin blister fluid were quantified by liquid
chromatography coupled to electrospray ionization tandem
mass spectrometry as described previously (30–32). Briefly,
skin fluid samples (typically 50–200 mL) were diluted with
methanol-water (15% w/w) up to 3 mL. Internal standards
(40 ng PGB2-d4 and 80 ng 12-HETE-d8; Cayman Chemicals)
were then added and resultant solutions acidified to pH 3.0,
followed by solid-phase extraction (C18-E cartridges; Phe-
nomenex) to reduce matrix effects and semi-purify the lipid
mediators. Eicosanoids were analyzed on a C18 column (Luna
5 mm; Phenomenex) by using a Waters Alliance 2695 HPLC
pump coupled to a triple-quadrupole mass spectrometer equipped
with an electrospray ionization probe (Quattro Ultima; Waters).
Instrument control and data acquisition were performed by
using MassLynx 4.0 software (Waters). Multiple-reaction
monitoring transitions used were as follows: PGE2, m/z 351 .
271; PGE1, m/z 353 . 317; PGE3, m/z 349 . 269; PGJ2, m/z
333 . 271; PGD1, m/z 353 . 317; PGD2, m/z 351 . 271;
PGF2a, m/z 353. 193; 13,14-dihydro-15-keto PGE2, m/z 351. 333;
13,14-dihydro-15-keto-PGE1, m/z 353 . 335; 12-HETE, m/z
319. 179; 11-HETE,m/z 319. 167; 15-HETE,m/z 319. 175; 15-
hydroxyeicosatrienoic acid, m/z 321. 221; 9-hydroxyoctadecadienoic
acid, m/z 295 . 171; and 13-hydroxyoctadecadienoic acid, m/z
295 . 195.
Urinary analysis of GTC metabolites
The urinary GTC metabolite epigallocatechin glucuronide
was assayed by liquid chromatography–tandem mass spec-
trometry as previously described (33) to establish compliance
with supplementation. Volunteers provided 24-h urine samples
before supplementation and after 1 d, 6 wk, and 12 wk of
supplementation.
Statistical analyses
Based on previous oral flavonoid photoprotection studies (34,
35), a sample size of at least 22 subjects per group was estimated
to be required to detect a 25% difference in the MED and UVR
erythema dose-response between groups, at a 5% significance
level with 90% power. Differences in UVR-induced in-
flammatory and eicosanoid responses between active and pla-
cebo groups postsupplementation were compared by ANCOVA
of ln-transformed data with baseline data as the covariate. Intent
to treat was the primary analysis for comparisons of outcomes
between treatment groups with multiple imputation of missing
data (n = 50). A per-protocol analysis was also performed (n =
45) to assess effectiveness of the supplementation. Wilcoxon’s
Signed Rank test was used to compare unexposed and UVR-
exposed skin within groups. Analyses were performed by using
SPSS 20 (SPSS, Inc.). Erythemal dose-response curves were
analyzed by using GraphPad Prism (v5.01; GraphPad Soft-
ware). Statistical significance was accepted at P , 0.05.
RESULTS
Study subjects and compliance
Of the 50 subjects recruited to the study, 25 were randomly
allocated to active supplementation and 25 to placebo. Baseline
characteristics of subjects are shown in Table 2. Four subjects
in the active group were noncompliant; 2 had a low concen-
tration of epigallocatechin glucuronide in urine at week 12, and
2 had missing urine samples for day 1 and week 12. One
subject in the placebo group was noncompliant due to a high
concentration of green tea metabolites in urine at day 1
(Figure 1). The BMI (in kg/m2) of the participants was un-
changed throughout the study, with a mean 6 SD of 27.7 6 5.0
and 25.5 6 4.0 in the active group and 27.9 6 5.4 and 25.3 6
3.8 in the placebo group at the 6- and 12-wk points, respectively.
The supplement was well tolerated; 6 subjects (5 in the active
group and 1 in the placebo group) reported occasional mild nausea
after ingestion.
TABLE 2
Baseline characteristics of subjects
Characteristic Active (n = 25) Placebo (n = 25)
Age, y 36 6 13.61 35 6 12.3
Sex, M/F, n 6/19 7/18
BMI, kg/m2 27.9 6 5.4 25.5 6 3.8
Skin type, I/II, n 3/22 1/24
MED,2 mJ/cm2 28 (12–48)3 28 (7–48)
1Mean 6 SD (all such values).
2MED, minimal erythema dose.
3Median; range in parentheses (all such values).
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Urinary excretion of epigallocatechin glucuronide
Urinary excretion of the green tea metabolite epigallocatechin
glucuronide by compliant participants in the active group is
shown in Figure 2. At baseline, 1 subject in the active group had
a low concentration of urinary epigallocatechin glucuronide
(AUC = 2094), whereas for all other subjects, the metabolite was
not detected. At 6 wk, mean concentration (AUC) in the active
group was 75,381 rising to 89,626 at 12 wk. In the placebo
group, epigallocatechin glucuronide was undetectable in all
subjects pre- and postsupplementation.
UVR erythema responses
Postsupplementation, there was no statistically significant dif-
ference in visual threshold erythema, that is, in the median MED
between the active (28 mJ/cm2; range: 16–48) and placebo (20 mJ/cm2;
range: 7–48) groups (P = 0.47; Figure 3A). AUC analysis for
the measured erythema induced by a series of 10 UVR doses
also revealed no statistically significant difference in the UVR
erythema dose-response between the 2 groups at baseline (mean
3423 vs. 3573, respectively; P = 0.67; Figure 3B) or post-
supplementation (mean 3555 vs. 3839; P = 0.44; Figure 3C).
Within-group analyses showed there was no statistically signif-
icant difference in median MED postsupplementation compared
with baseline for the active group (both 28 mJ/cm2; P = 0.17) or
placebo group (20 and 28 mJ/cm2, respectively; P = 0.12).
Dermal leukocytic infiltration
Immunohistochemical assessment of skin sections demon-
strated that the number of neutrophils and CD3+ T lymphocytes
in skin irradiated with 33 MED UVR was statistically signifi-
cantly higher than in unirradiated skin in both groups, both at
baseline and postsupplementation (all P , 0.01; Figure 4).
There was no statistically significant difference in neutrophil
numbers in UVR-irradiated skin between groups postsupplementation
(P = 0.85). Neutrophil numbers in UVR-exposed skin were
mean 6 SEM of 46.2 6 5.0 cells/hpf at baseline and 38.4 6 4.1
cells/hpf postsupplementation (P = 0.06) in the active group and
FIGURE 1 Number of participants randomly allocated and included in analyses. Fifty volunteers enrolled in the study between November 2010 and May
2011. The green tea group took 1350 mg green tea extract (containing 540 mg GTC) with 50 mg vitamin C twice daily. The placebo group took maltodextrin
twice daily. GTC, green tea catechin.
FIGURE 2 Excretion of EGC glucuronide in urine. Individual urinary
concentrations of EGC glucuronide are shown for compliant participants in
the active group (n = 18) expressed as area under curve per total urine
excreted over 24 h. EGC, epigallocatechin; Gluc, glucuronide; post-supp,
after supplementation.
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44.2 6 4.3 and 40.8 6 5.2 cells/hpf, respectively (P = 0.37), in
the placebo group. There was little change in the number of
CD3+ T cells in UVR-exposed skin from subjects in the active
group postsupplementation compared with baseline, with no
statistically significant difference between active and placebo
(P = 0.62; Figure 4). Similarly, no statistically significant dif-
ference between treatment groups was found after multiple
imputation or per-protocol analyses.
Cutaneous production of eicosanoids
We examined 15 eicosanoids, including those of principal
interest (i.e., PGE2 and 12-HETE). Concentrations of both PGE2
and 12-HETE in suction blister fluid from skin irradiated
with 33 MED UVR were significantly higher (mean increase
post-UVR of 161% for PGE2 and 233% for 12-HETE) than
in unirradiated skin in both groups, at baseline and post-
supplementation (all P , 0.05; Figure 5). Postsupplementation,
the mean 6 SEM concentration of PGE2 in blister fluid from
UVR-exposed skin of subjects in the active group (110.3 6
17.3 pg/mL) was not significantly different from placebo (137.36
FIGURE 3 UVR erythema responses at baseline and after 12 wk sup-
plementation. (A) Minimal erythema dose of solar-simulated UVR at base-
line and after supplementation with active or placebo treatment. Individual
data are shown with horizontal bars representing group medians. Mean 6
SEM DE is shown for each UVR dose at baseline (B) and post-supp (C). The
UVR erythema dose-response was plotted by using a 4-parameter logistic
curve (n = 25 active; n = 24 placebo). MED, minimal erythema dose; post-supp,
after supplementation; UVR, ultraviolet radiation; DE, difference in erythema
intensity between the UVR-exposed site and adjacent unexposed skin.
FIGURE 4 UVR-induced neutrophil and T-cell infiltration at baseline
and after 12 wk of supplementation. Representative immunohistochemistry
of (A) neutrophils and (B) CD3+ T cells in ultraviolet-exposed and unex-
posed skin at baseline and post-supp. Mean + SEM number of (C) neutro-
phils and (D) CD3+ T cells per high-power field (n = 22 active; n = 25
placebo). **P , 0.01 and ***P , 0.001, compared with unirradiated skin
(Wilcoxon’s Signed Rank test). hpf, high-power field; MED, minimal ery-
thema dose; post-supp, after supplementation; UVR, ultraviolet radiation.
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16.3 pg/mL; P = 0.35; Figure 5A). Similarly, there was no sig-
nificant difference in concentration of 12-HETE in UVR-exposed
skin between the active group (43.1 6 4.6 pg/mL) and the placebo
group (38.9 6 4.9 pg/mL; P = 0.45; Figure 5B). Results were
comparable after multiple imputation and per-protocol analyses.
Results for all eicosanoid species currently assayed in blister fluid
are presented in Supplemental Table 1. There was no statistically
significant impact of GTC supplementation on basal or UVR-
induced production of these eicosanoids.
DISCUSSION
Green tea is suspected to have benefits to health spanning
a wide range of inflammatory and immune-mediated disorders
(36), in addition to chemopreventive properties. However,
limited information is available from human studies, with most
data arising from experimental study of the most abundant
GTC: EGCG. Skin is exposed to and requires protection from
environmental UVR and itself provides an accessible organ for
direct assessment of impact of in vivo supplementation in
humans, facilitating noninvasive measurements, the adminis-
tration of external challenges, and comparative ease and safety
of tissue sampling. Our 3-mo supplementation trial was per-
formed under controlled conditions, evaluating the impact of
GTC ingestion on skin inflammatory status under basal con-
ditions and after a reproducible acute UVR challenge to assess
GTCs’ photoprotective potential.
In this double-blind randomized controlled trial, we found that
oral GTC supplementation taken with low-dose vitamin C did not
have a statistically significantly effect on the skin basal in-
flammatory status or the response to acute proinflammatory UVR
challenge, including clinical and histologic sunburn outcomes, or
their biochemical mediation through major proinflammatory
eicosanoids produced via the cyclooxygenase and lipoxygenase
pathways. Thus, compared with placebo, oral supplementation
with GTCs for 12 wk did not reduce UVR-induced inflammation
in terms of the clinical erythema response, assessed both visually
as the sunburn threshold (MED) and quantitatively across the
UVR erythema dose-response (AUC for UVR dose vs. erythema
index). Similarly, consumption of GTCs did not have a statisti-
cally significantly effect on infiltration of neutrophils or T cells
after UVR challenge. Finally, GTCs did not have a statistically
significantly effect on baseline or UVR-induced concentrations
of PGE2 and 12-HETE, which have roles in the mediation of
sunburn vasodilatation and chemoattraction, respectively (9).
These data were obtained from volunteers demonstrated to be
compliant with their supplementation.
There are several mechanisms by which GTCs might po-
tentially suppress the sunburn response, including down-
regulation of cyclooxygenase and/or lipoxygenase expression
as demonstrated in various cell models (18, 19, 37, 38). Other
mechanisms include reduced production of proinflammatory
and chemoattractant cytokines such as IL-1a and TNF-a, in-
hibition of T-cell proliferation (36), and upregulation of anti-
oxidant enzyme concentrations (39, 40). These activities are
supported by studies in rodent models, where green tea con-
stituents modulated nuclear transcription factor kB signaling
(24), attenuated UVR-induced cyclooxygenase activity (41),
and reduced neutrophil migration to sites of inflammation (22,
23). Topical application of GTCs was also reported to reduce
UVB-induced production of nitric oxide and hydrogen perox-
ide in a mouse model (42). In addition to the above, cyclo-
oxygenase and lipoxygenase are molecular targets for other
related polyphenols, with reports of reduced eicosanoid pro-
duction by lipoxygenase isoforms, including 12-lipoxygenase,
in vitro (43, 44).
The above mechanistic studies and our pilot human study (27)
indicated examination for the impact of oral GTC supplemen-
tation on the lipoxygenase metabolite and leukocyte chemo-
attractant 12-HETE, alongside cutaneous leukocyte infiltration.
We did not observe a statistically significant difference in neu-
trophil numbers between supplementation groups or any dif-
ference in 12-HETE concentrations. Although topical application
of GTCs before UVR exposure was reported to reduce UVB-
induced leukocyte infiltration in animal models (19, 42) and in
humans (25), the current study is the first to report the impact of
orally consumed GTCs on leukocyte infiltration and production
of cyclooxygenase/lipoxygenase metabolites in humans, as well
as after a solar-simulated radiation challenge.
The UVR erythema response findings in our double-blind
randomized controlled trial are in contrast to those in our previous
open, uncontrolled study indicating GTCs might protect against
UVR-induced erythema. This was a modest effect, evident as
a reduction of the measured erythema index at the highest dose of
FIGURE 5 UVR-induced PGE2 and 12-HETE production at baseline
and after 12 wk of supplementation. Mean 1 SEM concentration of (A)
PGE2 and (B) 12-HETE in suction blister fluid from UVR-exposed and
unexposed skin at baseline and post-supp (n = 20 active; n = 21 placebo).
* P , 0.05, ** P , 0.01, and *** P , 0.001 compared with unirradiated
skin (Wilcoxon’s Signed Rank test). MED, minimal erythema dose; PGE2,
prostaglandin E2; post-supp, after supplementation; UVR, ultraviolet radia-
tion; 12-HETE, 12-hydroxyeicosatetraenoic acid.
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UVR tested (27), and followed supplementation with 540 mg
GTC/d and 50 mg vitamin C/d (i.e., half the amount of the current
study). It is important to acknowledge the limitations of open,
uncontrolled studies, particularly the inability to allow for
changes in outcome measures during the course of supplemen-
tation that are unrelated to consumption of the supplement. There
is also the possibility of a nonlinear dose-response effect, because
higher concentrations of nutritional supplementation are some-
times reported to be less effective (e.g., 200 mg vitamin E/d was
more effective than 800 mg/d in enhancing T-cell responses in the
elderly) (45). However, the other published human study ex-
ploring the impact of orally consumed GTCs on sunburn, which
examined for and found a suppressive effect on the visual ery-
thema threshold (i.e., after a low-dose UVR challenge) used
a higher dose of GTCs (26). The participants were instructed
to consume 1 L/d of a green tea beverage (1402 mg GTC with
119 mg vitamin C daily); this also contained a higher proportion
of EGCG (daily: 100mg epicatechin, 980 mg EGCG, and 238 mg
epicatechin gallate) than our supplement (daily: 75 mg epi-
catechin, 436 mg EGCG, and 156 mg epicatechin gallate), and
this may be the most biologically active GTC (46). Other dif-
ferences are that in our pilot study, the subject group comprised
nearly all females, raising the possibility of a sex-specific effect;
the BMI of the group was lower; and the challenges posed to
rigorous blinding in a beverage study.
Strengths of this study include the double-blind randomized
controlled design, a statistically justified sample size, and bio-
chemical confirmation of subject compliance. We took an oral
consumption approach rather than topical application, thus
eliminating the possibility of a contribution of local protection
from the UVR challenge by a sunscreen effect (47) and with
greater relevance to human nutrition. Objective measurement of
sunburn erythema was made across the UVR dose series, en-
abling characterization of responses to threshold, moderate- and
high-dose solar-simulated UVR, and the impact of GTCs on
these. In view of ethical considerations and the range of samples
taken in this study, there was not scope to take further skin tissue
for assessment of target organ (i.e., skin) bioavailability of GTCs.
Potentially, interindividual variability in the types of catechins
and metabolites in skin postsupplementation, as demonstrated in
our pilot study (27), may influence outcomes.
We conclude that in a compliant mixed-sex study population,
the daily consumption of 1080 mg encapsulated GTC, equivalent
to 5 cups of green tea, taken with 100 mg vitamin C, does not
significantly affect the acute UVR-induced erythema (sunburn)
response, dermal leukocytic infiltration, or the cutaneous pro-
duction of proinflammatory cyclooxygenase and lipoxygenase
metabolites. Future studies might examine EGCG dose effect,
discuss the impact on other chemokines, and explore the skin
content of GTCs and their metabolites.
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